Novo Nordisk | NVO - EPS ربحية السهم


Fiscal التقويم فعلي إجماع السابق تاريخ
FY2026Q2 Jun/2026 0.96 0.80 0.93 Aug/04
FY2024Q3 Sep/2024 6.12 0.88 5.00 Nov/06
FY2024Q2 Jun/2024 4.49 4.32 Aug/07
FY2024Q1 Mar/2024 5.68 4.39 May/02
FY2023Q4 Dec/2023 0.72 0.67 6.02 Jan/31




Eps تغيير تاريخ
ANI Pharmaceuticals USD 2.21 0.16 2026-06
Aurora Cannabis CAD -0.13 0.51 2026-03
Bausch Health Companies USD 1.26 0.48 2026-06
Bristol-Myers Squibb USD 2.04 0.46 2026-06
Canopy Growth CAD -0.4 0.35 2026-03
Corcept Therapeutics USD 0.36 0.66 2026-06
Drreddys Laboratories INR 0.06 0.1 2026-03
Eli Lilly USD 8.38 0.17 2026-06
GlaxoSmithKline GBP 0.51 0.08 2026-06
Merck USD -0.13 1.15 2026-06
Nektar Therapeutics USD -1.78 0.43 2026-03
Novartis USD 2.41 0.42 2026-06
Novo Nordisk DKK 4.74 6.17 2026-06
Novo Nordisk DKK 0.96 9.95 2026-06
Pacira USD 0.73 0.13 2026-06
Perrigo USD 0.5 0.07 2026-06
Phibro Animal Health USD 0.78 0.1 2025-12
Prestige Brands USD 0.98 0.25 2026-06
Sanofi EUR 2.09 0.21 2026-06
Supernus Pharmaceuticals USD -1.01 1.61 2026-06
Zoetis USD 1.87 0.34 2026-06